The FDA just approved the Alzheimer’s drug Aduhelm, the first new Alzheimer’s drug in decades.
Here’s how it works.
Your Low-Stress Guide to Leveling-Up Your Bedtime Routine
Are You Burnt Out or Depressed?

The medication, brand name Aduhelm, is administered intravenously once a month.
Its purported to slow cognitive decline in individuals with mild disease.
The FDAs approval is not a wholesale endorsement of the drug, however.

…
The drug is also not cheap.
Theyre estimating approximately $4,300 per fusion, upwards of $56,000 on an annual basis, says Fuschillo.
Despite thisand the uncertainty around the drugs efficacyFuschillo says the AFA is cautiously optimistic about Aduhelm.

Were concerned about the cost of the drug, and the most common side effects, he says.
…
Got it, you’ve been added to our email list.



